The findings by scientists and physicians at the Mitchell Cancer Institute could be useful in developing a non-invasive test for pancreatic cancer diagnosis.
About Martin J. Heslin, M.D., M.S.H.A.
Martin J. Heslin, M.D., M.S.H.A., joined the Mitchell Cancer Institute (MCI) as director in February 2021.
Heslin is a renowned surgical oncologist and former associate director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham. He has served as executive vice chair of the Department of Surgery and is the chief of the medical staff at UAB Hospital. Heslin also was the James P. Hayes Jr. Endowed Professor in Gastrointestinal Oncology.
Heslin has extensive training in hepatobiliary, pancreatic and colorectal surgery, and maintains a clinical interest in gastrointestinal cancers including liver, pancreas, stomach, colon and rectum malignancies. His research has focused on a variety of topics from surgical outcomes to physician management.
He is author or co-author on more than 120 publications and 10 book chapters.